Febrile convulsions after 2010 seasonal trivalent influenza vaccine: Implications for vaccine safety surveillance in Australia

Medical Journal of Australia

Volumn 193, Issue 9, 2010, Pages 492-493

  Gold, Michael S ^a   Effler, Paul ^b   Kelly, Heath ^c   Richmond, Peter C ^d   Buttery, Jim P ^e,f  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b DEPARTMENT OF HEALTH   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AUSTRALIA; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FEBRILE CONVULSION; FEVER; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; POSTMARKETING SURVEILLANCE; RISK BENEFIT ANALYSIS;

EID: 78149319458     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb04029.x     Document Type: Editorial

References (12)

1. Therapeutic Goods Administration. Western Australian reports of adverse reactions to 2010 seasonal flu vaccine in children. http:// www.tga.gov.au/ alerts/medicines/fluvaccine.htm (accessed Jul 2010).
2. Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination: status report as at 2 July 2010. http://www.tga.gov.au/alerts/medicines/ fluvaccine-report100702.htm (accessed Jul 2010).
3. Gold M, Dugdale S, Woodman RJ, McCaul KA. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. Vaccine 2010; 28: 4308-4311.
4. Stokes B. Ministerial review into the public health response into the adverse events to the seasonal influenza vaccine. Perth: Government of Western Aus t ral ia, Depar tment of Health, 2010. http:// www.health.wa.gov.au/ publications/documents/Stokes-Report.pdf (accessed Sep 2010).
5. Lawrence G, Menzies R, Burgess M, et al. Surveillance of adverse events following immunisation: Australia, 2000-2002. Commun Dis Intell 2003; 27: 307-323.
6. Menzies R, Mahajan D, Gold MS, et al. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Commun Dis Intell 2009; 33: 365-581.
7. Lawrence G; National Immunisation Committee. National Vaccine Safety Workshop: summary and draft recommendations. Commun Dis Intell 2006; 30: 378-380.
8. Leask J, Booy R, McIntyre PB. MMR, Wakefield and The Lancet: what can we learn [editorial]? Med J Aust 2010; 193: 5-7.
9. Zurynski Y, Adams J, Booy R, et al. Paediatric active enhanced disease surveillance (PAEDS): a new surveillance mechanism for Australia. J Paediatr Child Health 2008; 44 (9): A16.
10. US Department of Health and Human Services, Health Resources and Services Administration. National Vaccine Injury Compensation Program, Vaccine Injury Compensation Trust Fund. http://www.hrsa.gov/vaccine-compensation/ VIC-Trust-Fund.htm (accessed Jul 2010).
11. Vaccine Adverse Event Reporting System. VAERS data. http:// vaers.hhs.gov/data/data/ (accessed Jul 2010).
12. US Department of Health and Human Services, Centers for Disease Control and Prevention. ACIP meeting agendas, minutes, registration, presentation slides, meeting dates. http://wwwtest.cdc.gov/vaccines/ recs/acip/meetings.htm (accessed Jul 2010).